Currency in SEK
| Earnings Estimate | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|
| No. of Analysts | 0 | 0 | 0 | 0 |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | N/A | N/A | N/A | N/A |
| Revenue Estimate | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|
| No. of Analysts | 0 | 0 | 1 | 1 |
| Avg. Estimate | N/A | N/A | 90M | 153M |
| Low Estimate | N/A | N/A | 90M | 153M |
| High Estimate | N/A | N/A | 90M | 153M |
| Year Ago Sales | N/A | N/A | 43.9M | 90M |
| Sales Growth (year/est) | N/A | N/A | 105.00% | 70.00% |
| Earnings History | Invalid Date | Invalid Date | Invalid Date | Invalid Date |
|---|
| EPS Est. | N/A | N/A | N/A | N/A |
| EPS Actual | N/A | N/A | N/A | N/A |
| Difference | N/A | N/A | N/A | N/A |
| Surprise % | N/A | N/A | N/A | N/A |
| EPS Trend | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | -0.45 | 0.61 |
| 30 Days Ago | 0 | 0 | -0.45 | 0.61 |
| 60 Days Ago | 0 | 0 | -0.45 | 0.61 |
| 90 Days Ago | 0 | 0 | -0.45 | 0.61 |
| EPS Revisions | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|
| Up Last 7 Days | N/A | N/A | N/A | N/A |
| Up Last 30 Days | N/A | N/A | N/A | N/A |
| Down Last 7 Days | N/A | N/A | N/A | N/A |
| Down Last 30 Days | N/A | N/A | N/A | N/A |
| Growth Estimates | BIOWKS.ST | Industry | Sector(s) | S&P 500 |
|---|
| Current Qtr. | N/A | N/A | N/A | N/A |
| Next Qtr. | N/A | N/A | N/A | N/A |
| Current Year | N/A | N/A | N/A | N/A |
| Next Year | N/A | N/A | N/A | N/A |
| Next 5 Years (per annum) | N/A | N/A | N/A | N/A |
| Past 5 Years (per annum) | N/A | N/A | N/A | N/A |
